Jeff Dantzler

Jeff Dantzler has extensive work experience in the biotech and pharmaceutical industry. Jeff is currently working as a Senior Scientist at Shape Therapeutics Inc., where they focus on purifying AAV viral vectors for gene editing and developing advanced AAV analytics capabilities. Previously, Jeff worked as a Principal Consultant at Dantzler Consulting, where they assisted Seattle area startups with designing biochemical assays, with a particular focus on drug development with viral vectors, biologics, and small molecules.

Prior to that, Jeff was a Senior Scientist at Umoja Biopharma, where they served as the Biochemistry Lead for the Analytical Development group. In this role, they were responsible for lentiviral vector characterization and release assay development. Jeff also worked at Good Therapeutics, Inc. as a Research Scientist, where they performed biosensor and ELISA analyses to identify drug candidates and engineered therapeutic proteins with targeted activity in the tumor microenvironment.

Jeff's earlier experience includes roles at Juno Therapeutics, Intellectual Ventures, Novo Nordisk A/S, Trubion Pharmaceuticals, and ICOS Corporation. At Juno Therapeutics, they worked as a Senior Associate Scientist in the Protein Sciences department, providing high-resolution kinetics and affinity data for CAR-T and T-cell engager projects. At Intellectual Ventures, Jeff contributed to the development of a rapid diagnostic test for M. tuberculosis and participated in a field trial in Uganda. At Novo Nordisk A/S, they contributed to various projects by providing high-quality biosensor data using Biacore T200 and Octet RED instruments. At Trubion Pharmaceuticals, Jeff worked as a Senior Research Associate, responsible for purifying protein reagents and therapeutic candidates. Lastly, at ICOS Corporation, they worked as a Research Associate, where they cloned, expressed, and purified therapeutic protein targets and developed enzymatic assays for high-throughput screening.

Overall, Jeff Dantzler has a diverse background in various aspects of biochemistry, assay development, viral vectors, and protein characterization, making him a highly skilled and experienced professional in the biotech and pharmaceutical industry.

Jeff Dantzler's education history includes attending the University of Washington, where they did not obtain a degree, as well as the University of Colorado Boulder, where they earned their B.A. in Biochemistry / Molecular, Cellular, & Developmental Biology. There is no information regarding the duration of their studies at these universities. Additionally, they have no recorded degree or field of study from the University of Maryland Baltimore County.

Jeff Dantzler also holds several additional certifications. Jeff obtained an edX Verified Certificate for Introduction to Computer Science and Programming Using Python from edX in July 2021. In June 2017, they obtained another edX certification, DAT203.1x: Data Science Essentials. Jeff also completed Emergency Spill Response Training (WA State) from EIC Environmental Health & Safety / James T. Denovan, Ph.D. in March 2010.